Therefore, CLL progression to a more aggressive disease depends not only on NOTCH1 mutations [63], but also on an aberrant NOTCH1 signaling activation fueled from the microenvironment [49]. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.